SARS and MERS: recent insights into emerging coronaviruses

de Wit, Emmie, van Doremalen, Neeltje, Falzarano, Darryl, Munster, Vincent J.·2016·Nature Reviews Microbiology

Cited by (1,002)

Items 401–500 of 1,002

  1. Structure-Based Stabilization of Non-native Protein–Protein Interactions of Coronavirus Nucleocapsid Proteins in Antiviral Drug Design
    Shanmeng Lin, Shih‐Chao Lin, Jia-Ning Hsu, Chung‐ke Chang, Ching‐Ming Chien, Yongsheng Wang, Hung‐Yi Wu, U‐Ser Jeng, Kylene Kehn‐Hall, Ming‐Hon Hou · 2020 · Journal of Medicinal Chemistry
  2. Radiological findings and clinical characteristics of pregnant women with COVID ‐19 pneumonia
    Xiaoqing Wu, Ruihong Sun, Jianpu Chen, Yuanliang Xie, Shutong Zhang, Xiang Wang · 2020 · International Journal of Gynecology & Obstetrics
  3. The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds - Additional weapons in the fight against the COVID-19 pandemic?
    Andréa D. Fuzimoto, Ciro Isidoro · 2020 · Journal of Traditional and Complementary Medicine
  4. Preliminary Study of Sars-Cov-2 Occurrence in Wastewater in the Czech Republic
    Hana Mlejnková, Kateřina Sovová, Petra Vašíčková, Věra Očenášková, Lucie Jašíková, Eva Juranová · 2020 · International Journal of Environmental Research and Public Health
  5. Pathological Role of Angiotensin II in Severe COVID-19
    Wolfgang Miesbach · 2020 · TH Open
  6. A shock like no other: coronavirus rattles commodity markets
    Himadri Rajput, Rahil Changotra, Prachi Rajput, Sneha Gautam, Anjani R.K. Gollakota, Amarpreet Singh Arora · 2020 · Environment Development and Sustainability
  7. COVID-19 pathways for brain and heart injury in comorbidity patients: A role of medical imaging and artificial intelligence-based COVID severity classification: A review
    Jasjit S. Suri, Anudeep Puvvula, Mainak Biswas, Misha Majhail, Luca Saba, Gavino Faa, Inder M. Singh, Ronald Oberleitner, Monika Turk, Paramjit S. Chadha et al. · 2020 · Computers in Biology and Medicine
  8. Angiotensin-converting enzyme 2 (ACE2): COVID 19 gate way to multiple organ failure syndromes
    Sundareswaran Loganathan, Maheshkumar Kuppusamy, Wankupar Wankhar, Krishna Rao Gurugubelli, Vidyashree Hodagatta Mahadevappa, Lhakit Lepcha, Arbind Kumar Choudhary · 2020 · Respiratory Physiology & Neurobiology
  9. Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain
    Adriana Carino, Federica Moraca, Bianca Fiorillo, Silvia Marchianò, Valentina Sepe, Michele Biagioli, Claudia Finamore, Silvia Bozza, Daniela Francisci, Eleonora Distrutti et al. · 2020 · Frontiers in Chemistry
  10. SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals
    Cecilie Bo Hansen, Ida Jarlhelt, Laura Pérez‐Alós, Lone Hummelshøj Landsy, Mette Loftager, Anne Rosbjerg, Charlotte Helgstrand, Jais Rose Bjelke, Thomas Egebjerg, Joseph G. Jardine et al. · 2020 · The Journal of Immunology
  11. Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19
    Kas Steuten, Heeyoung Kim, John C. Widen, Brett M. Babin, Ouma Onguka, Scott Lovell, Oguz Bolgi, Berati Cerikan, Christopher John Neufeldt, Mirko Cortese et al. · 2021 · ACS Infectious Diseases
  12. Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease
    Rachel M. Golonka, Piu Saha, Beng San Yeoh, Saurabh Chattopadhyay, Andrew T. Gewirtz, Bina Joe, Matam Vijay–Kumar · 2020 · Physiological Genomics
  13. Sinonasal pathophysiology of SARS‐CoV ‐2 and COVID ‐19: A systematic review of the current evidence
    Isabelle M. Gengler, James C. Wang, Marlene Maria Speth, Ahmad R. Sedaghat · 2020 · Laryngoscope Investigative Otolaryngology
  14. The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach
    Gerwyn Morris, Chiara C. Bortolasci, Basant K. Puri, LISA S. OLIVE, Wolfgang Marx, Adrienne E O'Neil, Eugene Athan, Andre Ferrer Carvalho, Michael H. J. Maes, Ken R. Walder et al. · 2020 · Life Sciences
  15. Prediction and Analysis of SARS-CoV-2-Targeting MicroRNA in Human Lung Epithelium
    Jonathan Tak-Sum Chow, Leonardo Salmena · 2020 · Genes
  16. COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells
    Andrea Latini, Emanuele Agolini, Antonio Novelli, Paola Borgiani, Rosalinda Giannini, Paolo Gravina, Andrea Smarrazzo, Mario Dauri, Massimo Andreoni, Paola Rogliani et al. · 2020 · Genes
  17. Animal models for COVID-19: advances, gaps and perspectives
    Changfa Fan, Yong Wu, Rui Xiong, Yuansong Yang, Chen Ling, Susu Liu, Shunan Liu, Youchun Wang · 2022 · Signal Transduction and Targeted Therapy
  18. A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques
    Neeltje van Doremalen, Elaine Haddock, Friederike Feldmann, Kimberly D. Meade-White, Trenton Bushmaker, Robert J. Fischer, Atsushi Okumura, Patrick W. Hanley, Greg A. Saturday, Nick J. Edwards et al. · 2020 · Science Advances
  19. Age-related mitochondrial dysfunction as a key factor in COVID-19 disease
    Daniel J.M. Fernández‐Ayala, Plácido Navas, Guillermo López‐Lluch · 2020 · Experimental Gerontology
  20. COVID-19: viral–host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection
    Francesco Messina, Emanuela Giombini, Chiara Agrati, Francesco Vairo, Tommaso Ascoli Bartoli, Samir Al Moghazi, Mauro Piacentini, Franco Locatelli, Gary Kobinger, Markus J. Maeurer et al. · 2020 · Journal of Translational Medicine
  21. The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions
    Tapan Behl, Ishnoor Kaur, SIMONA GABRIELA BUNGAU, Arun Kumar, Md. Sahab Uddin, Chanchal Kumar, Giridhari Pal, Sahil, Kamal Shrivastava, Gökhan Zengin et al. · 2020 · Life Sciences
  22. SARS-CoV-2 Antiviral Therapy
    Kaiming Tao, Philip L. Tzou, Janin Nouhin, Hector Fabio Bonilla, Prasanna Jagannathan, Robert W. Shafer · 2021 · Clinical Microbiology Reviews
  23. Infection and transmission of ancestral SARS-CoV-2 and its alpha variant in pregnant white-tailed deer
    Konner R. Cool, Natasha N. Gaudreault, Igor Morozov, Jessie D. Trujillo, David A. Meekins, Chester D. McDowell, Mariano Carossino, Dashzeveg Bold, Dana Mitzel, Taeyong Kwon et al. · 2021 · Emerging Microbes & Infections
  24. The management of coronavirus disease 2019 (COVID‐19)
    Liu, Jialin, Liu, Siru · 2020 · Journal of Medical Virology
  25. Comparative Pathogenesis of Bovine and Porcine Respiratory Coronaviruses in the Animal Host Species and SARS-CoV-2 in Humans
    Linda J. Saif, Kwonil Jung · 2020 · Journal of Clinical Microbiology
  26. Immune Response and COVID-19: A mirror image of Sepsis
    Eduardo López‐Collazo, José Avendaño Ortiz, Alejandro Martín‐Quirós, Luis Augusto Aguirre · 2020 · International Journal of Biological Sciences
  27. Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: Data from two Italian COVID-19 units
    Carubbi, Francesco, Salvati, Lia, Alunno, Alessia, Maggi, Fabio, Borghi, Erika, Mariani, Rinalda, Mai, Francesca, Paoloni, Maurizio, Ferri, Claudio, Desideri, Giovambattista et al. · 2021 · Scientific Reports
  28. COVID-19: The outbreak caused by a new coronavirus
    Erika Sifuentes-Rodriguez, Deborah Palacios-Reyes · 2020 · Boletín Médico del Hospital Infantil de México
  29. High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2
    Birgit Strodel, Olujide Oludayo Olubiyi, Maryam O. Olagunju, Monika Keutmann, Jennifer Loschwitz · 2020 · Molecules
  30. COVID-19 pneumonia and pregnancy; a systematic review and meta-analysis
    Maryam Kasraeian, Marjan Zare, Homeira Vafaei, Nasrin Asadi, Azam Faraji, Khadije Bazrafshan, Shohreh Roozmeh · 2020 · The Journal of Maternal-Fetal & Neonatal Medicine
  31. Translation and Replication Dynamics of Single RNA Viruses
    Sanne Boersma, Huib H. Rabouw, Lucas J. M. Bruurs, Tonja Pavlovič, Arno L. W. van Vliet, Joep Beumer, Hans C. Clevers, Frank J. M. van Kuppeveld, Marvin E. Tanenbaum · 2020 · Cell
  32. Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
    Marloes Grobben, Karlijn van der Straten, Philip J. M. Brouwer, Mitch Brinkkemper, Pauline Maisonnasse, Nathalie Dereuddre‐Bosquet, Brent Appelman, A. H. Ayesha Lavell, Lonneke A. van Vught, Judith A. Burger et al. · 2021 · eLife
  33. The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses
    Longping V. Tse, Rita M. Meganck, Rachel L. Graham, Ralph Steven Baric · 2020 · Frontiers in Microbiology
  34. Harnessing nitric oxide for preventing, limiting and treating the severe pulmonary consequences of COVID-19
    Nagasai C. Adusumilli, David Zhang, Joel M. Friedman, Adam Friedman · 2020 · Nitric Oxide
  35. The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
    Yun-yu Zhang, Bi-ru Li, Botao Ning · 2020 · Frontiers in Immunology
  36. COVID-19 Vaccine Candidates Based on Modified Vaccinia Virus Ankara Expressing the SARS-CoV-2 Spike Protein Induce Robust T- and B-Cell Immune Responses and Full Efficacy in Mice
    Juan García‐Arriaza, Urtzi Garaigorta, Patricia Pérez, Adrián Lázaro-Frías, Carmen Zamora, Pablo Gastaminza, Carlos del Fresno, José M. Casasnovas, Carlos Óscar S. Sorzano, David Sancho et al. · 2021 · Journal of Virology
  37. Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave
    Jonathan Michael Read, Chris A Green, Ewen Munro Harrison, Annemarie Beth Docherty, Sebastian Funk, Janet Harrison, Michelle Girvan, Hayley E. Hardwick, Lance C. W. Turtle, Jake W Dunning et al. · 2021 · The Lancet
  38. Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control
    Shen Wang, Wujian Li, Zhenshan Wang, Wanying Yang, Entao Li, Xianzhu Xia, Feihu Yan, Sandra Chiu · 2024 · Signal Transduction and Targeted Therapy
  39. Type 2 diabetes mellitus and COVID-19: a narrative review
    Corrao, Salvatore, Pinelli, Karen, Vacca, Martina, Raspanti, Massimo, Argano, Christiano · 2021 · Frontiers in Endocrinology
  40. MERS-CoV as an emerging respiratory illness: A review of prevention methods
    Salim A. Baharoon, Ziad Ahmed Memish · 2019 · Travel Medicine and Infectious Disease
  41. European Society For Emergency Medicine position paper on emergency medical systems’ response to COVID-19
    Luis Garcı́a-Castrillo, Roberta Petrino, Robert N. Leach, Christoph Dodt, Wilhelm Behringer, Abdo Khoury, Marc B. Sabbe · 2020 · European Journal of Emergency Medicine
  42. Pregnancy, Viral Infection, and COVID-19
    Ricardo Wesley Alberca, Nátalli Zanete Pereira, Luanda Mara da Silva Oliveira, Sarah Cristina Gozzi-Silva, Maria Notomi Sato · 2020 · Frontiers in Immunology
  43. COVID-19 and diabetes mellitus: how one pandemic worsens the other
    William S. Azar, Rachel Njeim, Angie H Fares, Nadim S. Azar, Sami T. Azar, Mazen J. El Sayed, Assaad Antoine Eid · 2020 · Reviews in Endocrine and Metabolic Disorders
  44. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2
    Johanna Signer, Hulda R. Jónsdóttir, Werner C. Albrich, Marc Strasser, Roland Züst, Sarah Ryter, Rahel Ackermann‐Gäumann, Nicole Lenz, Denise Siegrist, Andreas Suter et al. · 2020 · Virology Journal
  45. Promising terpenes as SARS-CoV-2 spike receptor-binding domain (RBD) attachment inhibitors to the human ACE2 receptor: Integrated computational approach
    Ziyad Tariq Muhseen, Alaa R. Hameed, Halah M. H. Al-Hasani, Muhammad Tahir ul Qamar, Guanglin Li · 2020 · Journal of Molecular Liquids
  46. Sustainable practice of ophthalmology during COVID-19: challenges and solutions
    Louis W. Lim, Leonard Wei Leon Yip, Hui Wen Tay, Xue Ling Ang, Llewellyn K. Lee, Chee Fang Chin, Vernon K.Y. Yong · 2020 · Graefe s Archive for Clinical and Experimental Ophthalmology
  47. Combating COVID-19 and Building Immune Resilience: A Potential Role for Magnesium Nutrition?
    Taylor C. Wallace · 2020 · Journal of the American College of Nutrition
  48. Targeting novel structural and functional features of coronavirus protease nsp5 (3CLpro, Mpro) in the age of COVID-19
    Molly K. Roe, Nathan A. Junod, Audrey R. Young, Dia C. Beachboard, Christopher C. Stobart · 2021 · Journal of General Virology
  49. Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection
    Komudi Singh, Yunching Chen, Shahin Hassanzadeh, Kim Han, Jennifer Judy, Fayaz Seifuddin, Ilker Tunc, Michael N. Sack, Mehdi Pirooznia · 2021 · Frontiers in Genetics
  50. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin
    Yisong Qian, Tianhua Lei, Parth S. Patel, Chi H Lee, Paula Monaghan-Nichols, Hong-Bo Xin, Jianming Qiu, Mingui Fu · 2021 · Journal of Virology
  51. NF-κB Signaling and Inflammation—Drug Repurposing to Treat Inflammatory Disorders?
    Annabell Roberti, Laura Chaffey, David R. Greaves · 2022 · Biology
  52. Clinical characteristics of 51 patients discharged from hospital with COVID-19 in Chongqing,China
    Lei Liu, Jian-Ya Gao, Wan-mei Hu, Xian-xiang Zhang, Lian Guo, Chun-qiu Liu, Yue-wu Tang, Chunhui Lang, Fangzheng Mou, Zheng-jun Yi et al. · 2020 · medRxiv
  53. SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets
    Jayalakshmi Vallamkondu, Albin A John, Willayat Yousuf Wani, S. Ramadevi, Kishore Kumar Jella, P. Hemachandra Reddy, Ramesh J. L. Kandimalla · 2020 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  54. Pregnancy and COVID-19: management and challenges
    Yao Wenling, Junchao Qiu, Zhirong Xiao, Shi Ouyang · 2020 · Revista do Instituto de Medicina Tropical de São Paulo
  55. Risk factors related to hepatic injury in patients with corona virus disease 2019
    Li Lu, Shuang Li, Manman Xu, Pengfei Yu, Sujun Zheng, Zhongping Duan, Jing Liu, Yu Chen, Junfeng Li · 2020 · medRxiv
  56. A Review of Zoonotic Pathogens of Dromedary Camels
    Sophie Zhu, Dawn M. Zimmerman, Sharon L. Deem · 2019 · EcoHealth
  57. Endangered wild salmon infected by newly discovered viruses
    Gideon J. Mordecai, Kristina M. Miller, Emiliano Di Cicco, Angela D. Schulze, Karia H. Kaukinen, Tobi J. Ming, Shaorong Li, Amy Tabata, Amy K. Teffer, David A. Patterson et al. · 2019 · eLife
  58. Heparin Therapy Improving Hypoxia in COVID-19 Patients – A Case Series
    Elnara Márcia Negri, Bruna Mamprim Piloto, Luciana Tamie Kato Morinaga, Carlos Jardim, Shari Anne El-Dash Lamy, Marcelo Alves Ferreira, Élbio Antônio D’Amico, Daniel Deheinzelin · 2020 · Frontiers in Physiology
  59. Expression of ACE2 in airways: Implication for COVID‐19 risk and disease management in patients with chronic inflammatory respiratory diseases
    Yin Yao, Hai Wang, Zheng Liu · 2020 · Clinical & Experimental Allergy
  60. Coronavirus hemagglutinin-esterase and spike proteins coevolve for functional balance and optimal virion avidity
    Yifei Lang, Wentao Li, Zeshi Li, Danielle Koerhuis, Arthur C. S. van den Burg, Erik H. Rozemuller, Berend‐Jan Bosch, Frank J. M. van Kuppeveld, Geert‐Jan Boons, Eric G. Huizinga et al. · 2020 · Proceedings of the National Academy of Sciences
  61. Targeting Lipid Rafts as a Strategy Against Coronavirus
    Maurizio Sorice, Roberta Misasi, Gloria Riitano, Valeria Manganelli, Stefano Martellucci, Agostina Longo, Tina Garofalo, Vincenzo Mattei · 2021 · Frontiers in Cell and Developmental Biology
  62. Origin, Potential Therapeutic Targets and Treatment for Coronavirus Disease (COVID-19)
    Muhammad Shahid Nadeem, Mazin Abdulaziz Zamzami, Hani Choudhry, Bibi Nazia Murtaza, Imran Ahmed Kazmi, Habib Ahmad, Abdul Rauf Shakoori · 2020 · Pathogens
  63. Molecular detection of SARS-CoV-2 in formalin-fixed, paraffin-embedded specimens
    Jun Liu, April M. Babka, Brian J. Kearney, Sheli R. Radoshitzky, Jens H. Kuhn, Xiankun Zeng · 2020 · JCI Insight
  64. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2
    Xueyan Zhang, Haojie Huang, Donglin Zhuang, Moussa Ide Nasser, Minghua Yang, Ping Zhu, Mingyi Zhao · 2020 · Infectious Diseases of Poverty
  65. KG-COVID-19: A Framework to Produce Customized Knowledge Graphs for COVID-19 Response
    Justin Reese, Deepak Raveendran Unni, Tiffany J. Callahan, Luca Cappelletti, Vida Ravanmehr, Seth Carbon, Kent Shefchek, Benjamin M. Good, James P. Balhoff, Tommaso Fontana et al. · 2020 · Patterns
  66. B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV
    Johannes F. Scheid, Christopher O. Barnes, Basak Eraslan, Andrew Hudak, Jennifer R. Keeffe, Lisa A. Cosimi, Eric Brown, Frauke Muecksch, Yiska Weisblum, Shuting Zhang et al. · 2021 · Cell
  67. Nature as a treasure trove of potential anti-SARS-CoV drug leads: a structural/mechanistic rationale
    Ahmed M. Sayed, Amira R. Khattab, Asmaa M. AboulMagd, Hossam M. Hassan, Mostafa Ezzat Rateb, Hala Zaid, Usama Ramadan Abdelmohsen · 2020 · RSC Advances
  68. Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): rapid systematic review and field synopsis
    Emilio Di Maria, Andrea Latini, Paola Borgiani, Giuseppe Novelli · 2020 · Human Genomics
  69. Long-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular Clinician
    Diana L. Tobler, Alix J. Pruzansky, Sahar Naderi, Andrew P. Ambrosy, Justin J. Slade · 2022 · Current Atherosclerosis Reports
  70. A Novel Coronavirus (COVID-19) Outbreak
    Yi Zhang, Jiuyang Xu, Hui Li, Bin Cao · 2020 · CHEST Journal
  71. A review of pathophysiology and neuropsychiatric manifestations of COVID-19
    Madhu Jasti, Krishna Nalleballe, Vasuki Dandu, Sanjeeva Reddy Onteddu · 2020 · Journal of Neurology
  72. Computational insights into tetracyclines as inhibitors against SARS-CoV-2 Mpro via combinatorial molecular simulation calculations
    Shiv Bharadwaj, Kyung Eun Lee, Vivek Dhar Dwivedi, Sang Gu Kang · 2020 · Life Sciences
  73. Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model
    Vincent Jacobus Munster, Daniel Wells, Teresa Lambe, Daniel Wright, Robert J. Fischer, Trenton Bushmaker, Greg A. Saturday, Neeltje van Doremalen, Sarah C. Gilbert, Emmie de Wit et al. · 2017 · npj Vaccines
  74. Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection
    Nazzarena Labò, Hidetaka Ohnuki, Giovanna Tosato · 2020 · Cells
  75. Frequent and Persistent Salivary Gland Ectasia and Oral Disease After COVID-19
    Enrico Felice Gherlone, Elisabetta Polizzi, Giulia Tetè, Rebecca DE LORENZO, Cristiano Magnaghi, Patrizia Querini Rovere, Fabio Ciceri · 2021 · Journal of Dental Research
  76. Aging, inflammaging and immunosenescence as risk factors of severe COVID-19
    Anteneh Mehari Tizazu, Hylemariam Mihiretie Mengist, Gebreselassie Demeke · 2022 · Immunity & Ageing
  77. A multiple-hit hypothesis involving reactive oxygen species and myeloperoxidase explains clinical deterioration and fatality in COVID-19
    Goud, Pravin T, Bai, David, Abu-Soud, Husam M · 2021 · International Journal of Biological Sciences
  78. Simultaneous detection of severe acute respiratory syndrome, Middle East respiratory syndrome, and related bat coronaviruses by real-time reverse transcription PCR
    Ji Yeong Noh, Sun‐Woo Yoon, Doo‐Jin Kim, Moo‐Seung Lee, Ji Hyung Kim, Woonsung Na, Daesub Song, Dae Gwin Jeong, Hye Kwon Kim · 2017 · Archives of Virology
  79. Efficacy of an Adjuvanted Middle East Respiratory Syndrome Coronavirus Spike Protein Vaccine in Dromedary Camels and Alpacas
    Danielle R. Adney, Lingshu Wang, Neeltje van Doremalen, Wei Shi, Yi Zhang, Wing‐Pui Kong, Megan R. Miller, Trenton Bushmaker, Dana P. Scott, Emmie de Wit et al. · 2019 · Viruses
  80. Weak Induction of Interferon Expression by Severe Acute Respiratory Syndrome Coronavirus 2 Supports Clinical Trials of Interferon-λ to Treat Early Coronavirus Disease 2019
    Thomas R. OʼBrien, David L. Thomas, Sarah S. Jackson, Ludmila Prokunina‐Olsson, Raymond P. Donnelly, Rune Hartmann · 2020 · Clinical Infectious Diseases
  81. Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomes
    Ruchi Jain, Sathishkumar Ramaswamy, Divinlal Harilal, Mohammed J. Uddin, Tom Loney, Norbert R. Nowotny, Hanan Sulaiman Al Suwaidi, Rupa Murthy Varghese, Zulfa Deesi, Abdulmajeed S. AlKhajeh et al. · 2020 · Computational and Structural Biotechnology Journal
  82. Spike Glycoprotein and Host Cell Determinants of SARS-CoV-2 Entry and Cytopathic Effects
    Hanh T. Nguyen, Shijian Zhang, Qian Wang, Saumya Anang, Jia Wang, Haitao Ding, John C. Kappes, Joseph Sodroski · 2020 · Journal of Virology
  83. The insert sequence in SARS-CoV-2 enhances spike protein cleavage by TMPRSS
    Tong Meng, Hao Cao, Hao Zhang, Zijian Kang, Da Xu, Haiyi Gong, Jing Wang, Zifu Li, Xingang Cui, Huji Xu et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  84. The Predictive Capacity of Air Travel Patterns during the Global Spread of the COVID-19 Pandemic: Risk, Uncertainty and Randomness
    Panayotis Christidis, Aris Christodoulou · 2020 · International Journal of Environmental Research and Public Health
  85. Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview
    Leila Mohamed Khosroshahi, Mohsen Rokni, Tahmineh Mokhtari, Farshid Noorbakhsh · 2021 · International Immunopharmacology
  86. Mucociliary Respiratory Epithelium Integrity in Molecular Defense and Susceptibility to Pulmonary Viral Infections
    Adivitiya, Manish Singh Kaushik, Soura Chakraborty, Shobi Veleri, Suneel Kateriya · 2021 · Biology
  87. Interleukin-6 Perpetrator of the COVID-19 Cytokine Storm
    Jyoti Kanwar Shekhawat, Kavya Gauba, Shruti Gupta, Purvi Purohit, Prasenjit Mitra, Mahendra Kumar Garg, Sanjeev Misra, Praveen Sharma, Mithu Banerjee · 2021 · Indian Journal of Clinical Biochemistry
  88. SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks”
    Benjamín L. Sievers, Mark T. K. Cheng, Kata Csiba, Bo Meng, Ravindra K. Gupta · 2023 · Cellular and Molecular Immunology
  89. Saracatinib Inhibits Middle East Respiratory Syndrome-Coronavirus Replication In Vitro
    Jin Soo Shin, Eunhye Jung, Meehyein Kim, Ralph Steven Baric, Yun Young Go · 2018 · Viruses
  90. Point-of-Care Diagnostics of COVID-19: From Current Work to Future Perspectives
    Heba A. Hussein, Rabeay Y. A. Hassan, Marco Chino, Ferdinando Febbraio · 2020 · Sensors
  91. Porcine Deltacoronaviruses: Origin, Evolution, Cross-Species Transmission and Zoonotic Potential
    Fanzhi Kong, Qiuhong Wang, Scott P. Kenney, Kwonil Jung, Anastasia Nickolaevna Vlasova, Linda J. Saif · 2022 · Pathogens
  92. The role of IL-6 in coronavirus, especially in COVID-19
    Xinyi Wang, Guozheng Tang, Yuchen Liu, Lizhi Zhang, Bang Chen, Yanxun Han, Zi-Yue Fu, Liuning Wang, Guang-Zhi Hu, Qing Ma et al. · 2022 · Frontiers in Pharmacology
  93. Systemic inflammation as fuel for acute liver injury in COVID-19
    M. Effenberger, C. Grander, F. Grabherr, A. Griesmacher, T. Ploner, F. Hartig, R. Bellmann-Weiler, M. Joannidis, H. Zoller, G. Weiss et al. · 2020 · Digestive and Liver Disease
  94. Kefir: A protective dietary supplementation against viral infection
    Reham Samir Hamida, Ashwag Shami, Mohamed Abdelaal Ali, Zakiah Nasser Almohawes, Afrah Eltayeb Mohammed, Mashael Mohammed Bin-Meferij · 2020 · Biomedicine & Pharmacotherapy
  95. COVID-19 in Germany and China: mitigation versus elimination strategy
    Guangyu Lu, Oliver Razum, Albrecht Jahn, Yuying Zhang, Brett A Sutton, Devi Sridhar, Koya Ariyoshi, Lorenz von Seidlein, Olaf Müller · 2021 · Global Health Action
  96. Oxidative Stress‐Related Mechanisms in SARS‐CoV‐2 Infections
    Joanna Wieczfińska, Paulina Kleniewska, Rafał Pawliczak · 2022 · Oxidative Medicine and Cellular Longevity
  97. Oral antiviral treatments for COVID-19: opportunities and challenges
    Laila Rahmah, Sunny Okechukwu Abarikwu, Amanuel Godana Arero, Mickael Essouma, Aliyu Tijani Jibril, Andrzej Fal, Robert Flisiak, Rangarirai Makuku, Leander Penaso Marquez, Kawthar Mohamed et al. · 2022 · Pharmacological Reports
  98. Potential COVID-2019 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches
    Alex A. Zhavoronkov, Vladimir Aladinskiy, Alexander Zhebrak, Bogdan A. Zagribelnyy, Victor A. Terentiev, Dmitry S. Bezrukov, Daniil A. Polykovskiy, Rim Shayakhmetov, Andrey Filimonov, Philipp S. Orekhov et al. · 2020 · ChemRxiv
  99. Risk factors for developing into critical COVID-19 patients in Wuhan, China: A multicenter, retrospective, cohort study
    Dan Liu, Pengfei Cui, Shaoqing Zeng, Siyuan Wang, Xinxia Feng, Sen Xu, Ruyuan Li, Yue Gao, Ruidi Yu, Ya Wang et al. · 2020 · EClinicalMedicine
  100. Biodiversity loss and COVID-19 pandemic: The role of bats in the origin and the spreading of the disease
    Sara Platto, Jinfeng Zhou, Yanqing Wang, Huo Wang, Ernesto Carafoli · 2020 · Biochemical and Biophysical Research Communications